225 related articles for article (PubMed ID: 20607487)
41. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone derivatives.
Chai Y; Wan ZL; Wang B; Guo HY; Liu ML
Eur J Med Chem; 2009 Oct; 44(10):4063-9. PubMed ID: 19481308
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and antibacterial activity of 5- and 6-hydroxy substituted 4-aminoquinolines and derivatives.
Meyer T; Lemcke T; Geffken D; Kaulfers PM
Pharmazie; 2001 Sep; 56(9):691-5. PubMed ID: 11593987
[TBL] [Abstract][Full Text] [Related]
43. Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents.
Guandalini L; Cellai C; Laurenzana A; Scapecchi S; Paoletti F; Romanelli MN
Bioorg Med Chem Lett; 2008 Sep; 18(18):5071-4. PubMed ID: 18723349
[TBL] [Abstract][Full Text] [Related]
44. [Synthesis of derivatives of (9S) -9-hydroxyl-12-methylene erythromycin A and their antibacterial activity in vitro].
Xu P; Yang Y; Shi Y; Lei PS; Liu L
Yao Xue Xue Bao; 2007 May; 42(5):497-501. PubMed ID: 17703771
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, characterization and antibacterial activity of 2-[1-(5-chloro-2-methoxy-phenyl)-5-methyl-1H-pyrazol-4-yl]-5-(substituted-phenyl)-[1,3,4]oxadiazoles.
Rai NP; Narayanaswamy VK; Shashikanth S; Arunachalam PN
Eur J Med Chem; 2009 Nov; 44(11):4522-7. PubMed ID: 19640616
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.
Wu XW; Wu ZP; Wang LX; Zhang HB; Chen JW; Zhang W; Gu LQ; Huang ZS; An LK
Eur J Med Chem; 2011 Sep; 46(9):4625-33. PubMed ID: 21839550
[TBL] [Abstract][Full Text] [Related]
47. Design, synthesis and antimicrobial evaluation of novel 1-benzyl 2-butyl-4-chloroimidazole embodied 4-azafluorenones via molecular hybridization approach.
Addla D; Bhima ; Sridhar B; Devi A; Kantevari S
Bioorg Med Chem Lett; 2012 Dec; 22(24):7475-80. PubMed ID: 23147074
[TBL] [Abstract][Full Text] [Related]
48. Novel chalcones and 1,3,5-triphenyl-2-pyrazoline derivatives as antibacterial agents.
Sivakumar PM; Ganesan S; Veluchamy P; Doble M
Chem Biol Drug Des; 2010 Nov; 76(5):407-11. PubMed ID: 20925692
[TBL] [Abstract][Full Text] [Related]
49. Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC.
Warmus JS; Quinn CL; Taylor C; Murphy ST; Johnson TA; Limberakis C; Ortwine D; Bronstein J; Pagano P; Knafels JD; Lightle S; Mochalkin I; Brideau R; Podoll T
Bioorg Med Chem Lett; 2012 Apr; 22(7):2536-43. PubMed ID: 22401863
[TBL] [Abstract][Full Text] [Related]
50. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and antibacterial activity of novel and potent DNA gyrase inhibitors with azole ring.
Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Suzuki K; Ueda T; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
Bioorg Med Chem; 2004 Nov; 12(21):5515-24. PubMed ID: 15465328
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of diverse analogues of Oenostacin and their antibacterial activities.
Srivastava V; Darokar MP; Fatima A; Kumar JK; Chowdhury C; Saxena HO; Dwivedi GR; Shrivastava K; Gupta V; Chattopadhyay SK; Luqman S; Gupta MM; Negi AS; Khanuja SP
Bioorg Med Chem; 2007 Jan; 15(1):518-25. PubMed ID: 17035037
[TBL] [Abstract][Full Text] [Related]
53. Physicochemical and biological characterization of novel macrocycles derived from o-phthalaldehyde.
Reddy PM; Ho YP; Shanker K; Rohini R; Ravinder V
Eur J Med Chem; 2009 Jun; 44(6):2621-5. PubMed ID: 18996622
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and antibacterial activities of a novel alkylide: 3-O-(3-aryl-2-propargyl) and 3-O-(3-aryl-2-propenyl)clarithromycin derivatives.
Liang JH; Wang YY; Wang H; Li XL; An K; Xu YC; Yao GW
Bioorg Med Chem Lett; 2010 May; 20(9):2880-3. PubMed ID: 20356738
[TBL] [Abstract][Full Text] [Related]
55. Design and synthesis of quinolinones as methionyl-tRNA synthetase inhibitors.
Farhanullah ; Kim SY; Yoon EJ; Choi EC; Kim S; Kang T; Samrin F; Puri S; Lee J
Bioorg Med Chem; 2006 Nov; 14(21):7154-9. PubMed ID: 16854585
[TBL] [Abstract][Full Text] [Related]
56. Syntheses of new isodethiaazacephems as potent antibacterial agents.
Hwu JR; Tsay SC; Hakimelahi S
J Med Chem; 1998 Nov; 41(24):4681-5. PubMed ID: 9822538
[TBL] [Abstract][Full Text] [Related]
57. Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
Bhandari K; Srinivas N; Shiva Keshava GB; Shukla PK
Eur J Med Chem; 2009 Jan; 44(1):437-47. PubMed ID: 18313805
[TBL] [Abstract][Full Text] [Related]
58. 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
Xiao ZP; Ouyang H; Wang XD; Lv PC; Huang ZJ; Yu SR; Yi TF; Yang YL; Zhu HL
Bioorg Med Chem; 2011 Jul; 19(13):3884-91. PubMed ID: 21669535
[TBL] [Abstract][Full Text] [Related]
59. Cyclopentanone ring-cleaved pleuromutilin derivatives.
Springer DM; Bunker A; Luh BY; Sorenson ME; Goodrich JT; Bronson JJ; DenBleyker K; Dougherty TJ; Fung-Tomc J
Eur J Med Chem; 2007 Jan; 42(1):109-13. PubMed ID: 17156897
[TBL] [Abstract][Full Text] [Related]
60. Design and synthesis of non-hydroxamate histone deacetylase inhibitors: identification of a selective histone acetylating agent.
Suzuki T; Matsuura A; Kouketsu A; Hisakawa S; Nakagawa H; Miyata N
Bioorg Med Chem; 2005 Jul; 13(13):4332-42. PubMed ID: 15927839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
